Learn about the FDA’s new expedited approval process for oral GLP-1 medications—a breakthrough that could transform obesity care. Host Maryam Tabatabai and Carole Kerzic talk about these once-daily pills, and their potential for the similar benefits as injectables without needles or refrigeration. With potential approval coming soon, oral GLP-1s could expand access, impact adherence, and help reshape the weight-loss market. Staying informed is critical: these drugs not only aid weight management but also improve cardiometabolic health. Tune in to learn why understanding the latest developments matters for payers, clinicians, patients, and policymakers.

GLP-1 Pipeline Update: November 2025

00:00 Overview

00:49 Introduction to oral GLP-1s

02:43 Evidence from clinical trials

10:28 Big picture if FDA approves oral GLP-1s

14:08 Must know: Non-peptide vs peptide

15:45 More patient friendly formulation?

17:38 Market & timing for oral GLP-s

Content in this podcast is for informational or educational purposes only. The content also does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen.